Aminopyridine derived compounds as LRRK2 inhibitors
The present invention is directed to aminopyridine derived compounds of formula (A) The compounds are considered useful for the treatment of diseases associated with LRRK2 such as a Lewy body dementia, Parkinson's disease or cancer.
Gespeichert in:
Hauptverfasser: | , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | DAVID LAURENT WILLIAMSON DOUGLAS STEWART MIKKELSEN GITTE KOBBERØE WATSON STEPHEN SMITH GARRICK PAUL CHEN I-JEN |
description | The present invention is directed to aminopyridine derived compounds of formula (A) The compounds are considered useful for the treatment of diseases associated with LRRK2 such as a Lewy body dementia, Parkinson's disease or cancer. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US9393248B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US9393248B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US9393248B13</originalsourceid><addsrcrecordid>eNrjZDB2zM3Myy-oLMpMycxLVUhJLcosS01RSM7PLcgvzUspVkgsVvAJCvI2UsjMy8hMyizJLyrmYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxocGWxpbGRiYWTobGRCgBAKoVLCU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Aminopyridine derived compounds as LRRK2 inhibitors</title><source>esp@cenet</source><creator>DAVID LAURENT ; WILLIAMSON DOUGLAS STEWART ; MIKKELSEN GITTE KOBBERØE ; WATSON STEPHEN ; SMITH GARRICK PAUL ; CHEN I-JEN</creator><creatorcontrib>DAVID LAURENT ; WILLIAMSON DOUGLAS STEWART ; MIKKELSEN GITTE KOBBERØE ; WATSON STEPHEN ; SMITH GARRICK PAUL ; CHEN I-JEN</creatorcontrib><description>The present invention is directed to aminopyridine derived compounds of formula (A) The compounds are considered useful for the treatment of diseases associated with LRRK2 such as a Lewy body dementia, Parkinson's disease or cancer.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160719&DB=EPODOC&CC=US&NR=9393248B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160719&DB=EPODOC&CC=US&NR=9393248B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DAVID LAURENT</creatorcontrib><creatorcontrib>WILLIAMSON DOUGLAS STEWART</creatorcontrib><creatorcontrib>MIKKELSEN GITTE KOBBERØE</creatorcontrib><creatorcontrib>WATSON STEPHEN</creatorcontrib><creatorcontrib>SMITH GARRICK PAUL</creatorcontrib><creatorcontrib>CHEN I-JEN</creatorcontrib><title>Aminopyridine derived compounds as LRRK2 inhibitors</title><description>The present invention is directed to aminopyridine derived compounds of formula (A) The compounds are considered useful for the treatment of diseases associated with LRRK2 such as a Lewy body dementia, Parkinson's disease or cancer.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDB2zM3Myy-oLMpMycxLVUhJLcosS01RSM7PLcgvzUspVkgsVvAJCvI2UsjMy8hMyizJLyrmYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxocGWxpbGRiYWTobGRCgBAKoVLCU</recordid><startdate>20160719</startdate><enddate>20160719</enddate><creator>DAVID LAURENT</creator><creator>WILLIAMSON DOUGLAS STEWART</creator><creator>MIKKELSEN GITTE KOBBERØE</creator><creator>WATSON STEPHEN</creator><creator>SMITH GARRICK PAUL</creator><creator>CHEN I-JEN</creator><scope>EVB</scope></search><sort><creationdate>20160719</creationdate><title>Aminopyridine derived compounds as LRRK2 inhibitors</title><author>DAVID LAURENT ; WILLIAMSON DOUGLAS STEWART ; MIKKELSEN GITTE KOBBERØE ; WATSON STEPHEN ; SMITH GARRICK PAUL ; CHEN I-JEN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US9393248B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2016</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>DAVID LAURENT</creatorcontrib><creatorcontrib>WILLIAMSON DOUGLAS STEWART</creatorcontrib><creatorcontrib>MIKKELSEN GITTE KOBBERØE</creatorcontrib><creatorcontrib>WATSON STEPHEN</creatorcontrib><creatorcontrib>SMITH GARRICK PAUL</creatorcontrib><creatorcontrib>CHEN I-JEN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DAVID LAURENT</au><au>WILLIAMSON DOUGLAS STEWART</au><au>MIKKELSEN GITTE KOBBERØE</au><au>WATSON STEPHEN</au><au>SMITH GARRICK PAUL</au><au>CHEN I-JEN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Aminopyridine derived compounds as LRRK2 inhibitors</title><date>2016-07-19</date><risdate>2016</risdate><abstract>The present invention is directed to aminopyridine derived compounds of formula (A) The compounds are considered useful for the treatment of diseases associated with LRRK2 such as a Lewy body dementia, Parkinson's disease or cancer.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_US9393248B1 |
source | esp@cenet |
subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
title | Aminopyridine derived compounds as LRRK2 inhibitors |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-20T20%3A08%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DAVID%20LAURENT&rft.date=2016-07-19&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS9393248B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |